메뉴 건너뛰기




Volumn 9781118299920, Issue , 2014, Pages 23-45

Polypharmacology and Adverse Bioactivity Profiles Predict Potential Toxicity and Drug-Related Adrs

Author keywords

Adverse bioactivity profiles; Drug related ADRs; Polypharmacology; Toxicity

Indexed keywords

BIOACTIVITY; FORECASTING; PHARMACOKINETICS; WELL TESTING;

EID: 84926399500     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118783344.ch2     Document Type: Chapter
Times cited : (2)

References (115)
  • 2
    • 4344645978 scopus 로고    scopus 로고
    • Can the pharmaceutical industry reduce attrition rates?
    • Kola, I., Landis, J. (2004). Can the pharmaceutical industry reduce attrition rates?. Nature Reviews Drug Discovery, 3, 711-715.
    • (2004) Nature Reviews Drug Discovery , vol.3 , pp. 711-715
    • Kola, I.1    Landis, J.2
  • 3
    • 24944547571 scopus 로고    scopus 로고
    • Why drugs fail-a study on side effects in new chemical entities
    • Schuster, D., Laggner, C., Langer, T. (2005). Why drugs fail-a study on side effects in new chemical entities. Current Pharmaceutical Design, 11, 3545-3559.
    • (2005) Current Pharmaceutical Design , vol.11 , pp. 3545-3559
    • Schuster, D.1    Laggner, C.2    Langer, T.3
  • 4
    • 72449126563 scopus 로고    scopus 로고
    • Recent advances in physicochemical and ADMET profiling in drug discovery
    • Wang, J., Skolnik, S. (2009). Recent advances in physicochemical and ADMET profiling in drug discovery. Chemistry & Biodiversity, 6, 1887-1899.
    • (2009) Chemistry & Biodiversity , vol.6 , pp. 1887-1899
    • Wang, J.1    Skolnik, S.2
  • 5
    • 85047683939 scopus 로고    scopus 로고
    • Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety
    • Wang, J., Urban, L., Bojanic, D. (2007). Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety. Expert Opinion on Drug Metabolism & Toxicology, 3, 641-665.
    • (2007) Expert Opinion on Drug Metabolism & Toxicology , vol.3 , pp. 641-665
    • Wang, J.1    Urban, L.2    Bojanic, D.3
  • 6
    • 68949119585 scopus 로고    scopus 로고
    • The topology of drugtarget interaction networks: Implicit dependence on drug properties and target families
    • Mestres, J., Gregori-Puigjané, E., Valverde, S., Solé, R.V. (2009). The topology of drugtarget interaction networks: Implicit dependence on drug properties and target families. Molecular Biosystems, 5, 1051-1057.
    • (2009) Molecular Biosystems , vol.5 , pp. 1051-1057
    • Mestres, J.1    Gregori-Puigjané, E.2    Valverde, S.3    Solé, R.V.4
  • 7
    • 41549108420 scopus 로고    scopus 로고
    • From single- to multi-target drugs in cancer therapy:When aspecificity becomes an advantage
    • Petrelli, A., Giordano, S. (2008). From single- to multi-target drugs in cancer therapy:When aspecificity becomes an advantage. Current Medicinal Chemistry, 15, 422-432.
    • (2008) Current Medicinal Chemistry , vol.15 , pp. 422-432
    • Petrelli, A.1    Giordano, S.2
  • 8
    • 75149130051 scopus 로고    scopus 로고
    • Targeting the cancer kinome through polypharmacology
    • Knight, Z.A., Lin, H., Shokat, K.M. (2010). Targeting the cancer kinome through polypharmacology. Nature Reviews: Cancer, 10, 130-137.
    • (2010) Nature Reviews: Cancer , vol.10 , pp. 130-137
    • Knight, Z.A.1    Lin, H.2    Shokat, K.M.3
  • 10
    • 54249155522 scopus 로고    scopus 로고
    • Network pharmacology: The next paradigm in drug discovery
    • Hopkins, A.L. (2008). Network pharmacology: The next paradigm in drug discovery. Nature Chemical Biology, 4, 682-690.
    • (2008) Nature Chemical Biology , vol.4 , pp. 682-690
    • Hopkins, A.L.1
  • 11
    • 33644858616 scopus 로고    scopus 로고
    • Selective optimization of side activities: The SOSA approach
    • Wermuth, C.G. (2006). Selective optimization of side activities: The SOSA approach. Drug Discovery Today, 11, 160-164.
    • (2006) Drug Discovery Today , vol.11 , pp. 160-164
    • Wermuth, C.G.1
  • 12
    • 33846822055 scopus 로고    scopus 로고
    • Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro
    • Wang, X., Douglas, S.D., Lai, J.P., Tuluc, F., Tebas, P., Ho, W.Z. (2007). Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro. Journal of NeuroImmune Pharmacology, 2, 42-48.
    • (2007) Journal of NeuroImmune Pharmacology , vol.2 , pp. 42-48
    • Wang, X.1    Douglas, S.D.2    Lai, J.P.3    Tuluc, F.4    Tebas, P.5    Ho, W.Z.6
  • 13
    • 78549255861 scopus 로고    scopus 로고
    • Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals
    • Manak, M.M., Moshkoff, D.A., Nguyen, L.T., Meshki, J., Tebas, P., Tuluc, F., Douglas, S.D. (2010). Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals. AIDS, 24, 2789-2796.
    • (2010) AIDS , vol.24 , pp. 2789-2796
    • Manak, M.M.1    Moshkoff, D.A.2    Nguyen, L.T.3    Meshki, J.4    Tebas, P.5    Tuluc, F.6    Douglas, S.D.7
  • 15
    • 84926404281 scopus 로고    scopus 로고
    • Use of thalidomide in leprosy
    • last accessed 10-02-2012
    • World Health Organization (WHO), Use of thalidomide in leprosy. http://www. who.int/lep/research/thalidomide/en/index.html last accessed 10-02-2012.
  • 16
    • 85192421766 scopus 로고    scopus 로고
    • last accessed 10-02
    • European Medicines Agency (EMEA), http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Summary_for_the_public/human/000823/WC500037052.pdf last accessed 10-02-2012.
    • (2012)
  • 17
    • 85192424460 scopus 로고    scopus 로고
    • last accessed 10-02
    • National Cancer Institute (NCI), http://www.cancer.gov/cancertopics/druginfo/fdathalidomide last accessed 10-02-2012.
    • (2012)
  • 18
    • 0345275778 scopus 로고    scopus 로고
    • Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the Gillette Review Series)
    • Pang, K.S. (2003). Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the Gillette Review Series). Drug Metabolism and Disposition, 31, 1507-1519.
    • (2003) Drug Metabolism and Disposition , vol.31 , pp. 1507-1519
    • Pang, K.S.1
  • 20
    • 8644243613 scopus 로고
    • Partition coefficients and their uses
    • Leo, A., Hansch, C., Elkins, D. (1971). Partition coefficients and their uses. Chemical Reviews, 71, 525-616.
    • (1971) Chemical Reviews , vol.71 , pp. 525-616
    • Leo, A.1    Hansch, C.2    Elkins, D.3
  • 21
    • 84906468942 scopus 로고    scopus 로고
    • Dissolution and solubility
    • B. Testa and H. Van de Waterbeemd (eds.), Elsevier, Oxford, UK
    • Avdeef, A., Voloboy, D., Foreman, A. Dissolution and solubility, in B. Testa and H. Van de Waterbeemd (eds.), Comprehensive Medicinal Chemistry II, Elsevier, Oxford, UK, 2007, pp. 399-423.
    • (2007) Comprehensive Medicinal Chemistry II , pp. 399-423
    • Avdeef, A.1    Voloboy, D.2    Foreman, A.3
  • 22
    • 60749101345 scopus 로고    scopus 로고
    • In vitro solubility assays in drug discovery
    • Kerns, E.H., Di, L., Carter, G.T. (2008). In vitro solubility assays in drug discovery. Current Drug Metabolism, 9, 879-885.
    • (2008) Current Drug Metabolism , vol.9 , pp. 879-885
    • Kerns, E.H.1    Di, L.2    Carter, G.T.3
  • 23
    • 0024593744 scopus 로고
    • Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
    • Hidalgo, I.J., Raub, T.J., Borchardt, R.T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736-749.
    • (1989) Gastroenterology , vol.96 , pp. 736-749
    • Hidalgo, I.J.1    Raub, T.J.2    Borchardt, R.T.3
  • 24
    • 32344446760 scopus 로고    scopus 로고
    • Role of Caco-2 cell monolayers in prediction of intestinal drug absorption
    • Shah, P., Jogani, V., Bagchi, T., Misra, A. (2006). Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnology Progress, 22, 186-198.
    • (2006) Biotechnology Progress , vol.22 , pp. 186-198
    • Shah, P.1    Jogani, V.2    Bagchi, T.3    Misra, A.4
  • 25
    • 0032568397 scopus 로고    scopus 로고
    • Physicochemical high throughput screening:Parallel artificial membrane permeation assay in the description of passive absorption processes
    • Kansy, M., Senner, F., Gubernator, K. (1998). Physicochemical high throughput screening:Parallel artificial membrane permeation assay in the description of passive absorption processes. Journal of Medicinal Chemistry, 41, 1007-1010.
    • (1998) Journal of Medicinal Chemistry , vol.41 , pp. 1007-1010
    • Kansy, M.1    Senner, F.2    Gubernator, K.3
  • 27
    • 79955690629 scopus 로고    scopus 로고
    • Guideline on the Investigation of Drug Interactions
    • last accessed 09-26
    • European Medicines Agency (EMA), Guideline on the Investigation of Drug Interactions. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/05/ WC500090112.pdf last accessed 09-26-2012.
    • (2012)
  • 28
    • 84865415281 scopus 로고    scopus 로고
    • Drug Interaction Studies-Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations
    • last accessed 09-29
    • (FDA), F. a. D. A., Drug Interaction Studies-Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htmlast accessed 09-29-2012.
    • (2012)
  • 29
    • 84879193652 scopus 로고    scopus 로고
    • In vitro models for plasma binding and tissue storage
    • B. Testa, H. Van de Waterbeemd (eds.), Elsevier, Oxford, UK
    • Barton, P., Austin, R.P., Fessey, R.E. In vitro models for plasma binding and tissue storage, in B. Testa, H. Van de Waterbeemd (eds.), Comprehensive Medicinal Chemistry II, Elsevier, Oxford, UK, 2007, pp. 21-340.
    • (2007) Comprehensive Medicinal Chemistry II , pp. 21-340
    • Barton, P.1    Austin, R.P.2    Fessey, R.E.3
  • 31
    • 34447503921 scopus 로고    scopus 로고
    • Glossary of terms used in toxicology
    • 2nd ed, IUPAC Recommendations 2007
    • Duffus, J.H., Nordberg, M., Templeton, D.M. (2007). Glossary of terms used in toxicology, 2nd ed. (IUPAC Recommendations 2007). 79, 1153-1344.
    • (2007) , vol.79 , pp. 1153-1344
    • Duffus, J.H.1    Nordberg, M.2    Templeton, D.M.3
  • 33
    • 0032169485 scopus 로고    scopus 로고
    • The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
    • Lehmann, J.M., McKee, D.D., Watson, M.A., Willson, T.M., Moore, J.T., Kliewer, S.A. (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. Journal of Clinical Investigation, 102, 1016-1023.
    • (1998) Journal of Clinical Investigation , vol.102 , pp. 1016-1023
    • Lehmann, J.M.1    McKee, D.D.2    Watson, M.A.3    Willson, T.M.4    Moore, J.T.5    Kliewer, S.A.6
  • 35
    • 33745395225 scopus 로고    scopus 로고
    • CYP induction-mediated drug interactions: In vitro assessment and clinical implications
    • Lin, J.H. (2006). CYP induction-mediated drug interactions: In vitro assessment and clinical implications. Pharmaceutical Research, 23, 1089-1116.
    • (2006) Pharmaceutical Research , vol.23 , pp. 1089-1116
    • Lin, J.H.1
  • 36
    • 53849084442 scopus 로고    scopus 로고
    • In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: Current status on methodologies and their utility for predicting drug-drug interactions
    • Fowler, S., Zhang, H. (2008). In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: Current status on methodologies and their utility for predicting drug-drug interactions. The AAPS Journal, 10, 410-424.
    • (2008) The AAPS Journal , vol.10 , pp. 410-424
    • Fowler, S.1    Zhang, H.2
  • 37
    • 37349113752 scopus 로고    scopus 로고
    • Medicinal importance of grapefruit juice and its interaction with various drugs
    • Kiani, J., Imam, S. Z. (2007). Medicinal importance of grapefruit juice and its interaction with various drugs. Nutrition Journal, 6, 33.
    • (2007) Nutrition Journal , vol.6 , pp. 33
    • Kiani, J.1    Imam, S.Z.2
  • 38
    • 39049168646 scopus 로고    scopus 로고
    • Understanding mechanisms of toxicity: Insights from drug discovery research
    • Houck, K.A., Kavlock, R.J. (2008). Understanding mechanisms of toxicity: Insights from drug discovery research. Toxicology and Applied Pharmacology, 227, 163-178.
    • (2008) Toxicology and Applied Pharmacology , vol.227 , pp. 163-178
    • Houck, K.A.1    Kavlock, R.J.2
  • 39
    • 0016685233 scopus 로고
    • Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test
    • Ames, B.N., Mccann, J., Yamasaki, E. (1975). Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutation Research, 31, 347-364.
    • (1975) Mutation Research , vol.31 , pp. 347-364
    • Ames, B.N.1    Mccann, J.2    Yamasaki, E.3
  • 40
    • 0016423549 scopus 로고
    • Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells
    • Clive, D., Spector, J. F. (1975). Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells. Mutation Research, 31, 17-29.
    • (1975) Mutation Research , vol.31 , pp. 17-29
    • Clive, D.1    Spector, J.F.2
  • 41
    • 0030805031 scopus 로고    scopus 로고
    • The in vitro micronucleus test: A multi-endpoint assay to detect simultaneously mitotic delay, apoptosis, chromosome breakage, chromosome loss and non-disjunction
    • Kirsch-Volders, M., Elhajouji, A., Cundari, E., Van Hummelen, P. (1997). The in vitro micronucleus test: A multi-endpoint assay to detect simultaneously mitotic delay, apoptosis, chromosome breakage, chromosome loss and non-disjunction. Mutation Research, 392, 19-30.
    • (1997) Mutation Research , vol.392 , pp. 19-30
    • Kirsch-Volders, M.1    Elhajouji, A.2    Cundari, E.3    Van Hummelen, P.4
  • 42
    • 33645317063 scopus 로고    scopus 로고
    • hERG potassium channels and cardiac arrhythmia
    • Sanguinetti, M.C., Tristani-Firouzi, M. (2006). hERG potassium channels and cardiac arrhythmia. Nature, 440, 463-469.
    • (2006) Nature , vol.440 , pp. 463-469
    • Sanguinetti, M.C.1    Tristani-Firouzi, M.2
  • 43
  • 45
    • 77249113148 scopus 로고    scopus 로고
    • The UV-filter benzophenone-1 inhibits 17beta-hydroxysteroid dehydrogenase type 3:Virtual screening as a strategy to identify potential endocrine disrupting chemicals
    • Nashev, L.G., Schuster, D., Laggner, C., Sodha, S., Langer, T., Wolber, G., Odermatt, A. (2010). The UV-filter benzophenone-1 inhibits 17beta-hydroxysteroid dehydrogenase type 3:Virtual screening as a strategy to identify potential endocrine disrupting chemicals. Biochemical Pharmacology, 79, 1189-1199.
    • (2010) Biochemical Pharmacology , vol.79 , pp. 1189-1199
    • Nashev, L.G.1    Schuster, D.2    Laggner, C.3    Sodha, S.4    Langer, T.5    Wolber, G.6    Odermatt, A.7
  • 47
    • 84875054110 scopus 로고    scopus 로고
    • Estrogen receptor alpha as a key target of organochlorines to promote angiogenesis
    • Clere, N., Lauret, E., Malthiery, Y., Andriantsitohaina, R., Faure, S. (2012). Estrogen receptor alpha as a key target of organochlorines to promote angiogenesis. Angiogenesis, 15, 745-760.
    • (2012) Angiogenesis , vol.15 , pp. 745-760
    • Clere, N.1    Lauret, E.2    Malthiery, Y.3    Andriantsitohaina, R.4    Faure, S.5
  • 48
    • 84864127720 scopus 로고    scopus 로고
    • The endocrine disruptor diethylstilbestrol induces adipocyte differentiation and promotes obesity in mice
    • Hao, C.J., Cheng, X.J., Xia, H.F., Ma, X. (2012). The endocrine disruptor diethylstilbestrol induces adipocyte differentiation and promotes obesity in mice. Toxicology and Applied Pharmacology, 263, 102-110.
    • (2012) Toxicology and Applied Pharmacology , vol.263 , pp. 102-110
    • Hao, C.J.1    Cheng, X.J.2    Xia, H.F.3    Ma, X.4
  • 49
    • 17644380257 scopus 로고    scopus 로고
    • Predicting drug disposition via application of BCS: Transport/ absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system
    • Wu, C.Y., Benet, L.Z. (2005). Predicting drug disposition via application of BCS: Transport/ absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharmaceutical Research, 22, 11-23.
    • (2005) Pharmaceutical Research , vol.22 , pp. 11-23
    • Wu, C.Y.1    Benet, L.Z.2
  • 50
  • 51
    • 0031024171 scopus 로고    scopus 로고
    • Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
    • Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23, 3-25.
    • (1997) Advanced Drug Delivery Reviews , vol.23 , pp. 3-25
    • Lipinski, C.A.1    Lombardo, F.2    Dominy, B.W.3    Feeney, P.J.4
  • 55
    • 46749095500 scopus 로고    scopus 로고
    • From virtuality to reality - Virtual screening in lead discovery and lead optimization: A medicinal chemistry perspective
    • Rester, U. (2008). From virtuality to reality - Virtual screening in lead discovery and lead optimization: A medicinal chemistry perspective. Current Opinion on Drug Discovery and Development, 11, 559-568.
    • (2008) Current Opinion on Drug Discovery and Development , vol.11 , pp. 559-568
    • Rester, U.1
  • 57
    • 79958865966 scopus 로고    scopus 로고
    • ComparativeQSARanalyses of competitiveCYP2C9 inhibitors using three-dimensional molecular descriptors
    • Lather,V., Fernandes, M.X. (2011). ComparativeQSARanalyses of competitiveCYP2C9 inhibitors using three-dimensional molecular descriptors. Chemical Biology & Drug Design, 78, 112-123.
    • (2011) Chemical Biology & Drug Design , vol.78 , pp. 112-123
    • Lather, V.1    Fernandes, M.X.2
  • 59
    • 68349150509 scopus 로고    scopus 로고
    • Fragment-based QSAR: Perspectives in drug design
    • Salum, L.B., Andricopulo, A.D. (2009). Fragment-based QSAR: Perspectives in drug design. Molecular Diversity, 13, 277-285.
    • (2009) Molecular Diversity , vol.13 , pp. 277-285
    • Salum, L.B.1    Andricopulo, A.D.2
  • 60
    • 84861507738 scopus 로고    scopus 로고
    • Using novel descriptor accounting for ligand-receptor interactions to define and visually explore biologically relevant chemical space
    • Rabal, O., Oyarzabal, J. (2012). Using novel descriptor accounting for ligand-receptor interactions to define and visually explore biologically relevant chemical space. Journal of Chemical Information and Modeling, 52, 1086-1102.
    • (2012) Journal of Chemical Information and Modeling , vol.52 , pp. 1086-1102
    • Rabal, O.1    Oyarzabal, J.2
  • 63
    • 85192415528 scopus 로고    scopus 로고
    • accessed 09-20
    • PASSonline. http://www.pharmaexpert.ru/passonline (accessed 09-20-2012).
    • (2012)
  • 64
    • 85192397313 scopus 로고    scopus 로고
    • accessed 10-04
    • OSIRIS property Explorer. http://www.organic-chemistry.org/prog/peo/ (accessed 10-04-2012).
    • (2012)
  • 65
    • 85192416549 scopus 로고    scopus 로고
    • 09-25
    • ADMETpredictor, http://www.simulationsplus.com/Products.aspx?grpID=1&cID=11&pID=13 09-25-2012.
    • (2012) ADMETpredictor
  • 66
    • 0034213636 scopus 로고    scopus 로고
    • Predicting blood-brain barrier permeation from three-dimensional molecular structure
    • Crivori, P., Cruciani, G., Carrupt, P.A., Testa, B. (2000). Predicting blood-brain barrier permeation from three-dimensional molecular structure. Journal of Medicinal Chemistry, 43, 2204-2216.
    • (2000) Journal of Medicinal Chemistry , vol.43 , pp. 2204-2216
    • Crivori, P.1    Cruciani, G.2    Carrupt, P.A.3    Testa, B.4
  • 67
    • 85192423471 scopus 로고    scopus 로고
    • Molecular Networks GmbH
    • Erlangen, Germany, 09-25
    • ADRIANA.Code, Molecular Networks GmbH, Erlangen, Germany, http://www. molecular-networks.com/products/adrianacode 09-25-2012.
    • (2012) ADRIANA.Code
  • 68
    • 85192422400 scopus 로고    scopus 로고
    • Molecular Networks GmbH
    • Erlangen, Germany, 09-25
    • SONNIA-Self-Organizing Neural Network Package, Molecular Networks GmbH, Erlangen, Germany, http://www.molecular-networks.com/products/sonnia 09-25-2012.
    • (2012) SONNIA-Self-Organizing Neural Network Package
  • 70
    • 13844320566 scopus 로고    scopus 로고
    • LigandScout: 3-D pharmacophores derived from proteinbound ligands and their use as virtual screening filters
    • Wolber, G., Langer, T. (2005). LigandScout: 3-D pharmacophores derived from proteinbound ligands and their use as virtual screening filters. Journal of Chemical Information and Modeling, 45, 160-169.
    • (2005) Journal of Chemical Information and Modeling , vol.45 , pp. 160-169
    • Wolber, G.1    Langer, T.2
  • 71
    • 37249062877 scopus 로고    scopus 로고
    • Accelrys Inc., San Diego, CA, USA, 10-02
    • Discovery Studio, Accelrys Inc., San Diego, CA, USA http://accelrys.com/products/discovery-studio/ 10-02-2012.
    • (2012) Discovery Studio
  • 72
    • 33745213575 scopus 로고    scopus 로고
    • PHASE: A novel approach to pharmacophore modeling and 3D database searching
    • Dixon, S.L., Smondyrev, A.M., Rao, S.N. (2006). PHASE: A novel approach to pharmacophore modeling and 3D database searching. Chemical Biology & Drug Design, 67, 370-372.
    • (2006) Chemical Biology & Drug Design , vol.67 , pp. 370-372
    • Dixon, S.L.1    Smondyrev, A.M.2    Rao, S.N.3
  • 73
    • 14944348527 scopus 로고    scopus 로고
    • A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction
    • Rush, T.S., Grant, J.A., Mosyak, L., Nicholls, A. (2005). A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. Journal of Medicinal Chemistry, 48, 1489-1495.
    • (2005) Journal of Medicinal Chemistry , vol.48 , pp. 1489-1495
    • Rush, T.S.1    Grant, J.A.2    Mosyak, L.3    Nicholls, A.4
  • 74
    • 78650721695 scopus 로고    scopus 로고
    • Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: Identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine
    • Waltenberger, B., Schuster, D., Paramapojn, S., Gritsanapan, W., Wolber, G., Rollinger, J.M., Stuppner, H. (2011). Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: Identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine. Phytomedicine, 18, 119-133.
    • (2011) Phytomedicine , vol.18 , pp. 119-133
    • Waltenberger, B.1    Schuster, D.2    Paramapojn, S.3    Gritsanapan, W.4    Wolber, G.5    Rollinger, J.M.6    Stuppner, H.7
  • 76
    • 85192429282 scopus 로고    scopus 로고
    • Inte:Ligand GmbH, Maria Enzersdorf, Austria, 2006-2012
    • last accessed 10-05
    • HypoDB. Inte:Ligand GmbH, Maria Enzersdorf, Austria, 2006-2012 http://www. inteligand.com/pharmdb/, last accessed 10-05-2012.
    • (2012)
  • 77
    • 77954264038 scopus 로고    scopus 로고
    • PharmMapper server: A web server for potential drug target identification using pharmacophore mapping approach
    • Liu, X., Ouyang, S., Yu, B., Liu, Y., Huang, K., Gong, J., Zheng, S., Li, Z., Li, H., Jiang, H. (2010). PharmMapper server: A web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Research, 38, W609-614.
    • (2010) Nucleic Acids Research , vol.38 , pp. W609-614
    • Liu, X.1    Ouyang, S.2    Yu, B.3    Liu, Y.4    Huang, K.5    Gong, J.6    Zheng, S.7    Li, Z.8    Li, H.9    Jiang, H.10
  • 79
    • 85192403203 scopus 로고    scopus 로고
    • CCDC, Cambridge, UK, last accessed 10-02-
    • Gold, CCDC, Cambridge, UK, http://www.ccdc.cam.ac.uk/products/life_sciences/gold/ last accessed 10-02-2012.
    • (2012) Gold
  • 80
    • 33748276474 scopus 로고    scopus 로고
    • Protein-ligand docking: current status and future challenges
    • Sousa, S.F., Fernandes, P.A., Ramos, M.J. (2006). Protein-ligand docking: current status and future challenges. Proteins, 65, 15-26.
    • (2006) Proteins , vol.65 , pp. 15-26
    • Sousa, S.F.1    Fernandes, P.A.2    Ramos, M.J.3
  • 83
    • 70350140380 scopus 로고    scopus 로고
    • Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter
    • Zheng, X., Ekins, S., Raufman, J.P., Polli, J.E. (2009). Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter. Molecular Pharmaceutics, 6, 1591-1603.
    • (2009) Molecular Pharmaceutics , vol.6 , pp. 1591-1603
    • Zheng, X.1    Ekins, S.2    Raufman, J.P.3    Polli, J.E.4
  • 84
    • 77953322016 scopus 로고    scopus 로고
    • Site of metabolism prediction on cytochrome P450 2C9:Aknowledge-based docking approach
    • Tarcsay, A., Kiss, R., Keseru, G.M. (2010). Site of metabolism prediction on cytochrome P450 2C9:Aknowledge-based docking approach. Journal of Computer-Aided Molecular Design, 24, 399-408.
    • (2010) Journal of Computer-Aided Molecular Design , vol.24 , pp. 399-408
    • Tarcsay, A.1    Kiss, R.2    Keseru, G.M.3
  • 85
    • 73649138207 scopus 로고    scopus 로고
    • Exploration of human serum albumin binding sites by docking and molecular dynamics flexible ligand-protein interactions
    • Deeb, O., Rosales-Hernández, M.C., Gómez-Castro, C., Garduño-Juárez, R., Correa-Basurto, J. (2010). Exploration of human serum albumin binding sites by docking and molecular dynamics flexible ligand-protein interactions. Biopolymers, 93, 161-170.
    • (2010) Biopolymers , vol.93 , pp. 161-170
    • Deeb, O.1    Rosales-Hernández, M.C.2    Gómez-Castro, C.3    Garduño-Juárez, R.4    Correa-Basurto, J.5
  • 86
    • 77954048869 scopus 로고    scopus 로고
    • Use of historic metabolic biotransformation data as a means of anticipating metabolic sites using MetaPrint2D and Bioclipse
    • Carlsson, L., Spjuth, O., Adams, S., Glen, R.C., Boyer, S. (2010). Use of historic metabolic biotransformation data as a means of anticipating metabolic sites using MetaPrint2D and Bioclipse. BMC Bioinformatics, 11, 362.
    • (2010) BMC Bioinformatics , vol.11 , pp. 362
    • Carlsson, L.1    Spjuth, O.2    Adams, S.3    Glen, R.C.4    Boyer, S.5
  • 88
    • 84862909453 scopus 로고    scopus 로고
    • Pharmacophore modeling, 3D-QSAR studies, and in-silico ADME prediction of pyrrolidine derivatives as neuraminidase inhibitors
    • Zhang, J., Pan, X., Wang, C., Wang, F., Li, P., Xu, W., He, L. (2012). Pharmacophore modeling, 3D-QSAR studies, and in-silico ADME prediction of pyrrolidine derivatives as neuraminidase inhibitors. Chemical Biology & Drug Design, 79, 353-359.
    • (2012) Chemical Biology & Drug Design , vol.79 , pp. 353-359
    • Zhang, J.1    Pan, X.2    Wang, C.3    Wang, F.4    Li, P.5    Xu, W.6    He, L.7
  • 90
    • 84864658770 scopus 로고    scopus 로고
    • Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity
    • Yadav, D.K., Khan, F., Negi, A.S. (2012). Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity. Journal of Molecular Modeling, 18, 2513-2525.
    • (2012) Journal of Molecular Modeling , vol.18 , pp. 2513-2525
    • Yadav, D.K.1    Khan, F.2    Negi, A.S.3
  • 91
    • 84926406092 scopus 로고    scopus 로고
    • News in brief: Network pharmacology moves into the clinic
    • (2012) News in brief: Network pharmacology moves into the clinic. Nature Reviews:Drug Discovery, 11, 589.
    • (2012) Nature Reviews:Drug Discovery , vol.11 , pp. 589
  • 92
  • 93
    • 82355160734 scopus 로고    scopus 로고
    • A critical assessment of combined ligand- and structure-based approaches to hERG channel blocker modeling
    • Du-Cuny, L., Chen, L., Zhang, S. (2011). A critical assessment of combined ligand- and structure-based approaches to hERG channel blocker modeling. Journal of Chemical Information and Modeling, 51, 2948-2960.
    • (2011) Journal of Chemical Information and Modeling , vol.51 , pp. 2948-2960
    • Du-Cuny, L.1    Chen, L.2    Zhang, S.3
  • 94
    • 18444374978 scopus 로고    scopus 로고
    • The identification of ligand features essential for PXR activation by pharmacophore modeling
    • Schuster, D., Langer, T. (2005). The identification of ligand features essential for PXR activation by pharmacophore modeling. Journal of Chemical Information and Modeling, 45, 431-439.
    • (2005) Journal of Chemical Information and Modeling , vol.45 , pp. 431-439
    • Schuster, D.1    Langer, T.2
  • 95
    • 58849086773 scopus 로고    scopus 로고
    • Data-driven homology modelling of P-glycoprotein in the ATP-bound state indicates flexibility of the transmembrane domains
    • Stockner, T., de Vries, S.J., Bonvin, A.M., Ecker, G.F., Chiba, P. (2009). Data-driven homology modelling of P-glycoprotein in the ATP-bound state indicates flexibility of the transmembrane domains. FEBS Journal, 276, 964-972.
    • (2009) FEBS Journal , vol.276 , pp. 964-972
    • Stockner, T.1    de Vries, S.J.2    Bonvin, A.M.3    Ecker, G.F.4    Chiba, P.5
  • 96
    • 84863820598 scopus 로고    scopus 로고
    • QSAR model for human pregnane X receptor (PXR) binding: Screening of environmental chemicals and correlations with genotoxicity, endocrine disruption and teratogenicity
    • Dybdahl, M., Nikolov, N.G.,Wedebye, E.B., Jónsdóttir, S., Niemelä, J.R. (2012). QSAR model for human pregnane X receptor (PXR) binding: Screening of environmental chemicals and correlations with genotoxicity, endocrine disruption and teratogenicity. Toxicology and Applied Pharmacology, 262, 301-309.
    • (2012) Toxicology and Applied Pharmacology , vol.262 , pp. 301-309
    • Dybdahl, M.1    Nikolov, N.G.2    Wedebye, E.B.3    Jónsdóttir, S.4    Niemelä, J.R.5
  • 98
    • 8844263008 scopus 로고    scopus 로고
    • Docking and scoring in virtual screening for drug discovery: methods and applications
    • Kitchen, D.B., Decornez, H., Furr, J.R., Bajorath, J. (2004). Docking and scoring in virtual screening for drug discovery: methods and applications. Nature Reviews: Drug Discovery, 3, 935-949.
    • (2004) Nature Reviews: Drug Discovery , vol.3 , pp. 935-949
    • Kitchen, D.B.1    Decornez, H.2    Furr, J.R.3    Bajorath, J.4
  • 99
    • 85047683680 scopus 로고    scopus 로고
    • In silico prediction of ADMET properties: How far have we come?
    • Dearden, J.C. (2007). In silico prediction of ADMET properties: How far have we come?. Expert Opinion on Drug Metabolism & Toxicology, 3, 635-639.
    • (2007) Expert Opinion on Drug Metabolism & Toxicology , vol.3 , pp. 635-639
    • Dearden, J.C.1
  • 101
    • 84862018461 scopus 로고    scopus 로고
    • Application of support vector machine to three-dimensional shape-based virtual screening using comprehensive three-dimensional molecular shape overlay with known inhibitors
    • Sato, T., Yuki, H., Takaya, D., Sasaki, S., Tanaka, A., Honma, T. (2012). Application of support vector machine to three-dimensional shape-based virtual screening using comprehensive three-dimensional molecular shape overlay with known inhibitors. Journal of Chemical Information and Modeling, 52, 1015-1026.
    • (2012) Journal of Chemical Information and Modeling , vol.52 , pp. 1015-1026
    • Sato, T.1    Yuki, H.2    Takaya, D.3    Sasaki, S.4    Tanaka, A.5    Honma, T.6
  • 102
    • 78650750102 scopus 로고    scopus 로고
    • 3D pharmacophores as tools for activity profiling
    • Schuster, D. (2010). 3D pharmacophores as tools for activity profiling. Drug Discovery Today: Technologies, 7, 205-211.
    • (2010) Drug Discovery Today: Technologies , vol.7 , pp. 205-211
    • Schuster, D.1
  • 103
    • 79951512210 scopus 로고    scopus 로고
    • Strategies to discover unexpected targets for drugs active at G protein-coupled receptors
    • Allen, J.A., Roth, B.L. (2011). Strategies to discover unexpected targets for drugs active at G protein-coupled receptors. Annual Reviews of Pharmacology and Toxicology, 51, 117-144.
    • (2011) Annual Reviews of Pharmacology and Toxicology , vol.51 , pp. 117-144
    • Allen, J.A.1    Roth, B.L.2
  • 104
    • 0036835460 scopus 로고    scopus 로고
    • Integration of virtual and high-throughput screening
    • Bajorath, J. (2002). Integration of virtual and high-throughput screening. Nature Reviews:Drug Discovery, 1, 882-894.
    • (2002) Nature Reviews:Drug Discovery , vol.1 , pp. 882-894
    • Bajorath, J.1
  • 108
    • 79551667504 scopus 로고    scopus 로고
    • In-silico ADME models: A general assessment of their utility in drug discovery applications
    • Gleeson, M.P., Hersey, A., Hannongbua, S. (2011). In-silico ADME models: A general assessment of their utility in drug discovery applications. Current Topics in Medicinal Chemistry, 11, 358-381.
    • (2011) Current Topics in Medicinal Chemistry , vol.11 , pp. 358-381
    • Gleeson, M.P.1    Hersey, A.2    Hannongbua, S.3
  • 111
    • 27644596457 scopus 로고    scopus 로고
    • Predicting in vivo drug interactions from in vitro drug discovery data
    • Wienkers, L.C., Heath, T.G. (2005). Predicting in vivo drug interactions from in vitro drug discovery data. Nature Reviews: Drug Discovery, 4, 825-833.
    • (2005) Nature Reviews: Drug Discovery , vol.4 , pp. 825-833
    • Wienkers, L.C.1    Heath, T.G.2
  • 112
    • 79953100964 scopus 로고    scopus 로고
    • Structure-based systems biology for analyzing off-target binding
    • Xie, L., Bourne, P.E. (2011). Structure-based systems biology for analyzing off-target binding. Current Opinion in Structural Biology, 21, 189-199.
    • (2011) Current Opinion in Structural Biology , vol.21 , pp. 189-199
    • Xie, L.1    Bourne, P.E.2
  • 114
    • 84863012821 scopus 로고    scopus 로고
    • Systems biology and systems chemistry: New directions for drug discovery
    • Brown, J.B., Okuno, Y. (2012). Systems biology and systems chemistry: New directions for drug discovery. Chemistry & Biology, 19, 23-28.
    • (2012) Chemistry & Biology , vol.19 , pp. 23-28
    • Brown, J.B.1    Okuno, Y.2
  • 115
    • 79952935246 scopus 로고    scopus 로고
    • Maximizing the outcome of earlyADMETmodels: Strategies to win the drug-hunting battles?
    • Wang, J., Collis, A. (2011). Maximizing the outcome of earlyADMETmodels: Strategies to win the drug-hunting battles?. Expert Opinion on Drug Metabolism & Toxicology, 7, 381-386.
    • (2011) Expert Opinion on Drug Metabolism & Toxicology , vol.7 , pp. 381-386
    • Wang, J.1    Collis, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.